"The ability to directly interface with the brain safely and effectively has advanced to the point where BCIs can leave the lab and produce practical, real-world benefits for patients with paralysis. “Getting BCI technology into the hands of patients will be life-changing for them, their caregivers and their communities,” Solzbacher said.
Until now, patients could only access this technology through multimillion-dollar research studies, but that is changing: Blackrock expects its first commercial BCI device—and the first commercially available implantable BCI in the world—to be available in 2023"